Table I.
General clinical data of patients in the three groups [n (%), mean ± SD].
| Variable | Group A (n=50) | Group B (n=50) | Group C (n=50) | F/χ2 | P-value |
|---|---|---|---|---|---|
| Age (years) | 7.43±3.76 | 7.14±3.19 | 7.51±3.55 | 0.15 | 0.86 |
| Sex | |||||
| Male | 23 (46) | 25 (50) | 26 (52) | 0.37 | 0.83 |
| Female | 27 (54) | 25 (50) | 24 (48) | ||
| Body weight (kg) | 25.12±4.73 | 24.82±3.91 | 25.43±4.11 | 0.26 | 0.77 |
| BMI (kg/cm2) | 22.86±3.82 | 23.81±4.12 | 23.87±4.33 | 0.95 | 0.39 |
| Lymphoblasts and prolymphocytes (%) | 55.78±11.76 | 58.24±12.22 | 56.91±10.93 | 0.56 | 0.57 |
| White blood cells (109/liter) | 64.32±11.43 | 59.82±9.78 | 62.86±10.98 | 2.28 | 0.11 |
| Platelets (109/liter) | 54.09±16.22 | 57.82±15.97 | 53.87±14.93 | 1.00 | 0.37 |
| Immunophenotype | |||||
| B subtype | 31 (62) | 28 (56) | 20 (40) | 0.39 | 0.82 |
| T subtype | 19 (38) | 22 (44) | 30 (60) | ||